DCM Shriram Limited

DCM Shriram Ltd. reported resilient FY 2025-26 performance with a 12% increase in consolidated net revenue to ₹14,264 crore. PBDIT grew by 15% to ₹1,694 crore, and Profit After Tax increased significantly by 42% to ₹856 crore, which includes a one-time deferred tax credit of ₹239 crore. The company's performance was driven by strong volume growth in the Chemicals business, sustained growth in Fenesta Building Systems and Shriram Farm Solutions, and improved operational efficiencies. The Board recommends a final dividend of 200%.

DCM Shriram Ltd. announced the convening of its 37th Annual General Meeting (AGM) on August 18, 2026. The Board of Directors approved the audited financial results for the year ended March 31, 2026, and recommended a final dividend of 200% (₹4 per share). They also approved the cancellation of 39,00,000 forfeited equity shares and a capital expenditure plan for Hindusthan Specialty Chemicals Ltd, a subsidiary, with financial assistance up to ₹100 crores.

DCM Shriram Ltd's board has recommended to shareholders the cancellation of 39,00,000 forfeited equity shares at its meeting on May 13, 2026. The board also approved the audited financial results for the year ended March 31, 2026, and recommended a final dividend of 200% (₹4 per share). The 37th AGM will be held on August 18, 2026. Additionally, the board approved a capital expenditure plan for Hindusthan Specialty Chemicals Ltd and financial assistance of up to ₹100 crores.

DCM Shriram Ltd's board recommended a final dividend of 200%, or ₹4 per share (face value ₹2), for FY26, subject to shareholder approval at the 37th AGM on August 18, 2026. If approved, the total dividend for FY26 will be 560%, or ₹11.20 per share, including two interim dividends of 180% each. The board also approved the audited financial results for FY26 and the cancellation of 39,00,000 forfeited equity shares. Additionally, it considered and approved financial assistance of up to ₹100 crores to its subsidiary, Hindusthan Specialty Chemicals Ltd, for capacity expansion.

DCM Shriram Ltd's board recommended a final dividend of 200% (₹4 per share) for FY26, subject to shareholder approval at the AGM on August 18, 2026. If approved, the total dividend for FY26 will be 560% (₹11.20 per share), including two interim dividends of 180% each. The board also approved the audited financial results for FY26 and the cancellation of 39,00,000 forfeited equity shares. Additionally, it considered and approved financial assistance of up to ₹100 crores to Hindusthan Specialty Chemicals Ltd for capacity expansion.

DCM Shriram Ltd's board approved the audited financial results for the year ended March 31, 2026, and recommended a final dividend of 200% (₹4 per share). This brings the total dividend for FY26 to 560% (₹11.20 per share). The board also approved convening the 37th AGM on August 18, 2026, and considered the cancellation of 39,00,000 forfeited equity shares. Additionally, they approved a ₹100 crore financial assistance to Hindusthan Specialty Chemicals Ltd for capacity expansion.

DCM Shriram Ltd's board approved the audited financial results for FY26 and recommended a final dividend of 200% (₹4 per share). The 37th AGM will be held on August 18, 2026. The board also approved the cancellation of 39,00,000 forfeited equity shares and a capital expenditure plan for its subsidiary, Hindusthan Specialty Chemicals Ltd (HSCL).

DCM Shriram Ltd's board approved the audited financial results for the quarter and year ended March 31, 2026. A final dividend of 200% (₹4 per share) was recommended, subject to shareholder approval at the AGM on August 18, 2026. If approved, the total dividend for FY26 would be ₹11.20 per share, including interim dividends. The board also approved the cancellation of 39,00,000 forfeited equity shares and a ₹101 crore capital expenditure plan for Hindusthan Specialty Chemicals Ltd (HSCL).

DCM Shriram Ltd. has executed a Tripartite Agreement on May 4, 2026, with MCS Share Transfer Agent Limited (erstwhile RTA) and Kfin Technologies Limited (new RTA). This agreement complies with Regulation 7(5) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The information is available on the company's website.

DCM Shriram Ltd has scheduled a Board of Directors meeting on May 13, 2026, to consider and approve the audited financial results (standalone and consolidated) for the quarter and year ended March 31, 2026. The board will also consider the recommendation of a final dividend for the financial year 2025-26. The trading window is closed from April 1, 2026, until 48 hours after the declaration of the results, i.e., up to May 15, 2026.